Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Raw Materials (2018 - 2025)

Historic Raw Materials for Dna X (SONM) over the last 8 years, with Q3 2025 value amounting to $8.1 million.

  • Dna X's Raw Materials rose 2350.96% to $8.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.1 million, marking a year-over-year increase of 2350.96%. This contributed to the annual value of $5.6 million for FY2024, which is 64540.61% up from last year.
  • Per Dna X's latest filing, its Raw Materials stood at $8.1 million for Q3 2025, which was up 2350.96% from $6.3 million recorded in Q2 2025.
  • Dna X's Raw Materials' 5-year high stood at $8.1 million during Q3 2025, with a 5-year trough of $3000.0 in Q2 2023.
  • Its 5-year average for Raw Materials is $2.6 million, with a median of $2.2 million in 2021.
  • As far as peak fluctuations go, Dna X's Raw Materials tumbled by 9962.33% in 2023, and later surged by 7790000.0% in 2024.
  • Over the past 5 years, Dna X's Raw Materials (Quarter) stood at $2.0 million in 2021, then tumbled by 99.3% to $14000.0 in 2022, then skyrocketed by 5264.29% to $751000.0 in 2023, then surged by 645.41% to $5.6 million in 2024, then soared by 44.34% to $8.1 million in 2025.
  • Its Raw Materials was $8.1 million in Q3 2025, compared to $6.3 million in Q2 2025 and $4.3 million in Q1 2025.